New York City-based Mount Sinai’s Tisch Cancer Center has launched a new AI platform designed to help more cancer patients across its health system find and enroll in clinical trials. The platform, ...
Patient-centric trial aiming to evaluate whether bezisterim can help delay disease progression reaches enrollment milestone -- Topline Results ...
Westcove Partners, LLC ("Westcove"), a highly specialized investment bank, announced that it acted as the exclusive financial advisor to Tampa Bay Medical Research ("TBMR") in its partnership with ...
The good news at the end of the year was that the FDA approved a pill form of the company's GLP-1 weight loss medication. The ...
JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 clinical trial of JADE101 ...
One way Takeda lives out its values is by striving to ensure that patients are aware of and can access the company’s clinical ...
Northwell Health has formed a strategic partnership with The START Center for Cancer Research to launch a $5.7 million, 10,000-square-foot early-phase clinical trials center at the Lake Success-based ...
Somerville, Mass.-based Mass General Brigham has spun out an AI startup it says represents a “breakthrough” for clinical trial patient identification. The academic health system said Dec. 12 it ...
New integrations with industry leaders in EDC, eConsent, IRT/RTSM, eCOA, payments, and patient engagement expands Advarra's connected ecosystem, giving sponsors, CROs, and research sites secure, ...
CARTERVILLE, Ill. (WSIL) — Southern Illinois Healthcare (SIH) is opening the door to some of the most advanced cancer treatments in the world, announcing that patients in the region now have access to ...
Paradigm Health has raised $78 million as it works to revamp the clinical research ecosystem, while also announcing a deal to acquire Flatiron Health's clinical research business unit. With the ...
Eli Lilly and Co. and Indiana University announced a new agreement that would see the drugmaker provide up to $40 million over five years to the university to bolster clinical trials and enhance care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback